top of page

Nytricx, Inc. is a University of Georgia (UGA-Athens) spinoff company, developing nitric oxide (NO)-releasing anti-microbial medical devices.  Nytricx is dedicated to developing safe, effective, and cutting-edge device solutions that reduce complications, enhance healing, and improve treatment outcomes in critical medical applications

Pharmacological Properties of Nitric Oxide

NO Pharmacuetical Properties.jpg

Advantages of Nitric Oxide and Nytricx NO Technology

​

  • Nitric Oxide is part of the body's innate immune system with broad anti-microbial and anti-thrombotic efficacy

  • Nitric Oxide does not induce drug resistance

  • Nytricx NORel (Nitric Oxide Release) technology has sustained (up to 30-day) activity

  • NORel does not generate toxic species and is cyto-compatible

©2023 by Nytricx, Inc. Created with Wix.com

bottom of page